Inventor · disambiguated record
Adam Mullick
Also filed as: MULLICK ADAM
3 granted patents·12 pending applications·11 citations·filing 2012–2025
64Inventor score
Top patents by PatentIndex Score
15 records- 0188US10912792B2Compounds and methods for modulating angiotensinogen expressionIONIS PHARMACEUTICALS INC·Filed 2016·Granted Feb 9, 2021·4 cites·11 claims
- 0282US9157082B2Modulation of apolipoprotein CIII (ApoCIII) expressionMULLICK ADAM·Filed 2012·Granted Oct 13, 2015·7 cites·45 claims
- 0371US2024401061A1Compounds and methods for reducing pln expressionIONIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0471US2025243487A1Compounds and Methods for Reducing APOCIII ExpressionIONIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0570US11447521B2Compounds and methods for modulating angiotensinogen expressionIONIS PHARMACEUTICALS INC·Filed 2021·Granted Sep 20, 2022·0 cites·25 claims
- 0668US2025340888A1Compounds and methods for reducing pln expressionIONIS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0767US2025215044A1Compounds and Methods for Inhibiting LPAIONIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0866US2022298200A1Compounds and methods for modulating angiotensinogen expressionIONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0963US2022000901A1Compounds and methods for modulating angiotensinogen expressionIONIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1062US2020056176A1Modulation of apolipoprotein ciii (apociii) expressionIONIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1158US2024191232A1Compounds and methods for reducing pln expressionIONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1256US2017268004A1Modulation of apolipoprotein ciii (apociii) expressionIONIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1352US2022243210A1Angiotensin ii type 1 receptor targeted oligonucleotides and uses thereofIONIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1451US2016060625A1Modulation of apolipoprotein ciii (apociii) expressionISIS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1549US2015297629A1Modulation of renin-angiotensin system (ras) related diseases by angiotensinogenISIS PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Adam Mullick files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →